Global Endocrine Testing Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Tests
08. Market Segmentation by Diagnostic Technology
08.1 Global Clinical Chemistry Technology Market
08.1.1 Market Size and Forecast
08.2 Global Immunoassay Technology Market
08.2.1 Market Size and Forecast
08.3 Global Monoclonal and Polyclonal Antibodies Technology Market
08.3.1 Market Size and Forecast
08.4 Global Tandem Mass Spectrometry Technology Market
08.4.1 Market Size and Forecast
08.5 Global Sensor Technology Market
08.5.1 Market Size and Forecast
09. Geographical Segmentation
09.1 Endocrine Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 Endocrine Testing Market in EMEA
09.2.1 Market Size and Forecast
09.3 Endocrine Testing Market in APAC
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Abbott
17.2.2 DiaSorin
17.2.3 Roche
17.2.4 Siemens Healthcare
17.2.5 Thermo Fisher
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Diagnostics
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Geographical Presence
18.1.4 SWOT Analysis
18.2 DiaSorin
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Geographical Segmentation by Revenue 2013
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 Roche Diagnostics
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2014
18.3.4 Business Segmentation by Revenue 2013 and 2014
18.3.5 Geographical Segmentation by Revenue 2014
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Siemens Healthcare Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 SWOT Analysis
18.5 Thermo Fisher Scientific
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation by Revenue 2014
18.5.4 Business Segmentation by Revenue 2013 and 2014
18.5.5 Geographical Segmentation by Revenue 2014
18.5.6 Business Strategy
18.5.7 Recent Developments
18.5.8 SWOT Analysis
19. Other Reports in this Series